US4447A
(en)
|
|
1846-04-04 |
|
Car- wheel |
US233A
(en)
|
|
1837-06-14 |
|
Improvement in plows |
US3180193A
(en)
|
1963-02-25 |
1965-04-27 |
Benedict David |
Machines for cutting lengths of strip material
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
CA1023287A
(fr)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Procede de fixation d'une proteine sur un substrat
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
CA1093991A
(fr)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Traduction non-disponible
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
EP0173494A3
(fr)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Récepteurs chimériques par liaison et expression de l'ADN
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
JPS63502716A
(ja)
|
1986-03-07 |
1988-10-13 |
マサチューセッツ・インステチュート・オブ・テクノロジー |
糖タンパク安定性の強化方法
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
EP0307434B2
(fr)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Anticorps alteres
|
DE3856559T2
(de)
|
1987-05-21 |
2004-04-29 |
Micromet Ag |
Multifunktionelle Proteine mit vorbestimmter Zielsetzung
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5683888A
(en)
|
1989-07-22 |
1997-11-04 |
University Of Wales College Of Medicine |
Modified bioluminescent proteins and their use
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
AU633698B2
(en)
|
1990-01-12 |
1993-02-04 |
Amgen Fremont Inc. |
Generation of xenogeneic antibodies
|
FR2664073A1
(fr)
|
1990-06-29 |
1992-01-03 |
Thomson Csf |
Moyens de marquage d'objets, procede de realisation et dispositif de lecture.
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
EP0546091B1
(fr)
|
1990-08-29 |
2007-01-24 |
Pharming Intellectual Property BV |
Recombinaison homologue dans des cellules de mammiferes
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
WO1992003918A1
(fr)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Animaux non humains transgeniques capables de produire des anticorps heterologues
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
CA2105984C
(fr)
|
1991-03-11 |
2002-11-26 |
Milton J. Cormier |
Clonage et expression de la luciferase de renilla
|
WO1992022670A1
(fr)
|
1991-06-12 |
1992-12-23 |
Genpharm International, Inc. |
Detection precoce d'embryons transgeniques
|
WO1992022645A1
(fr)
|
1991-06-14 |
1992-12-23 |
Genpharm International, Inc. |
Animaux transgeniques non humains presentant une deficience immunitaire
|
EP1400536A1
(fr)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Procédé pour fabriquer des anticorps humanisés
|
WO1993004169A1
(fr)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Ciblage de genes dans des cellules animales au moyen de produits de synthese d'adn isogeniques
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
EP0746609A4
(fr)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
Animaux transgeniques non humains capables de produire des anticorps heterologues
|
CA2135313A1
(fr)
|
1992-06-18 |
1994-01-06 |
Theodore Choi |
Methodes pour l'obtention d'animaux transgeniques, comportant un chromosome artificiel de levure
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
DK0672141T3
(da)
|
1992-10-23 |
2003-06-10 |
Immunex Corp |
Fremgangsmåder til fremstilling af opløselige, oligomere proteiner
|
US5981175A
(en)
|
1993-01-07 |
1999-11-09 |
Genpharm Internation, Inc. |
Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome
|
EP0754225A4
(fr)
|
1993-04-26 |
2001-01-31 |
Genpharm Int |
Animaux transgeniques capables de produire des anticorps heterologues
|
WO1995007463A1
(fr)
|
1993-09-10 |
1995-03-16 |
The Trustees Of Columbia University In The City Of New York |
Methodes d'utilisation de proteines fluorescentes vertes
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
WO1995021191A1
(fr)
|
1994-02-04 |
1995-08-10 |
William Ward |
Indicateur bioluminescent fonde sur l'expression d'un gene codant pour une proteine modifiee a fluorescence verte
|
US5643763A
(en)
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
US5777079A
(en)
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
EP1978033A3
(fr)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Anticorps humains dérivés à partir de xénosouris immunisée
|
CA2219486A1
(fr)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Anticorps humains derives de xeno-souris immunisees
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
CA2229043C
(fr)
|
1995-08-18 |
2016-06-07 |
Morphosys Gesellschaft Fur Proteinoptimierung Mbh |
Banques de proteines/(poly)peptides
|
CN101333516A
(zh)
|
1995-08-29 |
2008-12-31 |
麒麟医药株式会社 |
嵌合体动物及其制备方法
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
US5804387A
(en)
|
1996-02-01 |
1998-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
FACS-optimized mutants of the green fluorescent protein (GFP)
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
US5925558A
(en)
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
CA2616914C
(fr)
|
1996-12-03 |
2012-05-29 |
Abgenix, Inc. |
Anticorps de liaison de recepteur d'egf
|
AU741076B2
(en)
|
1996-12-12 |
2001-11-22 |
Prolume, Ltd. |
Apparatus and method for detecting and identifying infectious agents
|
ES2258817T3
(es)
|
1997-05-21 |
2006-09-01 |
Biovation Limited |
Metodo para la produccion de proteinas no inmunogenas.
|
EP1064360B1
(fr)
|
1998-03-27 |
2008-03-05 |
Prolume, Ltd. |
Luciferases, proteines fluorescentes gfp, leurs acides nucleiques, et leur utilisation en diagnostic
|
NZ507381A
(en)
|
1998-04-21 |
2003-12-19 |
Micromet Ag |
CD19xCD3 specific polypeptides and uses thereof
|
DK1100830T3
(da)
|
1998-07-28 |
2004-01-19 |
Micromet Ag |
Heterominiantistoffer
|
EP1051432B1
(fr)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Modification de l'immunogenicite de proteines
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
US7435871B2
(en)
|
2001-11-30 |
2008-10-14 |
Amgen Fremont Inc. |
Transgenic animals bearing human Igλ light chain genes
|
BRPI0415457A
(pt)
|
2003-10-16 |
2006-12-05 |
Micromet Ag |
constructo de ligação especìfico de cd3 citotoxicamente ativo, seu processo de produção, composição compreendendo o mesmo, seqüência de ácido nucléico, vetor, hospedeiro, seus usos na preparação de uma composição farmacêutica e kit compreendendo os mesmo
|
US8236308B2
(en)
|
2005-10-11 |
2012-08-07 |
Micromet Ag |
Composition comprising cross-species-specific antibodies and uses thereof
|
CN101687915B8
(zh)
|
2007-04-03 |
2018-08-03 |
安进研发(慕尼黑)股份有限公司 |
跨物种特异性CD3-ε结合结构域
|
EP2352765B1
(fr)
|
2008-10-01 |
2018-01-03 |
Amgen Research (Munich) GmbH |
Anticorps monocaténaire bispécifique à domaine unique, spécifique d'espèces croisées
|
RS54655B2
(sr)
*
|
2009-10-27 |
2021-04-29 |
Amgen Res Munich Gmbh |
Dozni režim za primenu cd19xcd3 bispecifičnog antitela
|
WO2013026837A1
(fr)
|
2011-08-23 |
2013-02-28 |
Roche Glycart Ag |
Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t.
|
JP6339015B2
(ja)
|
2011-08-23 |
2018-06-06 |
ロシュ グリクアート アーゲー |
二重特異性t細胞活性化抗原結合分子
|
BR112015010318A2
(pt)
|
2012-11-08 |
2017-08-22 |
Albumedix As |
Variantes de albumina
|
EP2970484B2
(fr)
|
2013-03-15 |
2022-09-21 |
Amgen Inc. |
Anticorps hétérodimères bispécifiques
|
US20140308285A1
(en)
|
2013-03-15 |
2014-10-16 |
Amgen Inc. |
Heterodimeric bispecific antibodies
|
US20140302037A1
(en)
|
2013-03-15 |
2014-10-09 |
Amgen Inc. |
BISPECIFIC-Fc MOLECULES
|
JP6071725B2
(ja)
|
2013-04-23 |
2017-02-01 |
カルソニックカンセイ株式会社 |
電気自動車の駆動力制御装置
|
AR097648A1
(es)
*
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
WO2015048272A1
(fr)
|
2013-09-25 |
2015-04-02 |
Amgen Inc. |
Anticorps v-c-fc-v-c
|
US9212225B1
(en)
*
|
2014-07-01 |
2015-12-15 |
Amphivena Therapeutics, Inc. |
Bispecific CD33 and CD3 binding proteins
|
US10105142B2
(en)
|
2014-09-18 |
2018-10-23 |
Ethicon Llc |
Surgical stapler with plurality of cutting elements
|
JP2018516248A
(ja)
*
|
2015-05-29 |
2018-06-21 |
アンフィヴェナ セラピューティクス,インク. |
二重特異性のcd33およびcd3結合タンパク質を使用する方法
|
KR20180023968A
(ko)
*
|
2015-07-02 |
2018-03-07 |
셀진 코포레이션 |
혈액암 및 충실성 종양의 치료를 위한 병용 요법
|
EA039859B1
(ru)
*
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
JOP20170091B1
(ar)
*
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|